Select a year to access the Company’s financial statements together with the accompanying MD&A. Each period below includes both required disclosure files for that reporting date.
Audited year-end MD&A and financial statements for March 2025, including discussion of operating results, liquidity, capital resources, and key year-end judgments and estimates.
Interim MD&A and financial statements for April 2025, providing updated commentary on operating performance, cash flows, and significant subsequent events following the March 2025 year-end.
Q2 2025 MD&A and accompanying financial statements for the period ended May 31, 2025, covering segment performance, capital allocation, and management’s outlook for the second half of the year.
Interim MD&A and financial statements for August 2025, including updated operating metrics, liquidity analysis, and management’s commentary on risks and opportunities for the balance of the year.